Get started
Author

Edward Laane

Mapping the human genetic architecture of COVID-19
2021 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics InitiativeLeadership, et al. · Nature · 983
Whole-genome sequencing reveals host factors underlying critical COVID-19
2022 · Athanasios Kousathanas, Erola Pairo-Castineira, et al. · Nature · 327
PDF
Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy
2009 · E Laane, K Pokrovskaja Tamm, et al. · Cell Death and Differentiation · 208
A first update on mapping the human genetic architecture of COVID-19
2022 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics Initiative, et al. · Nature · 181
PDF
EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
2025 · Meletios A. Dimopoulos, Evangelos Terpos, et al. · Nature Reviews Clinical Oncology · 165
PDF
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
2013 · Ulf-Henrik Mellqvist, Peter Gimsing, et al. · Blood · 139
PDF
Doxorubicin Requires the Sequential Activation of Caspase-2, Protein Kinase Cδ, and c-Jun NH2-terminal Kinase to Induce Apoptosis
2005 · Theocharis Panaretakis, Edward Laane, et al. · Molecular Biology of the Cell · 102
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
2018 · Mohamad Mohty, Mohamad Mohty, et al. · Clinical Lymphoma Myeloma & Leukemia · 82
Investigation and management of IgM and Waldenström‐associated peripheral neuropathies: recommendations from the IWWM ‐8 consensus panel
2017 · Shirley D'Sa, Marie José Kersten, et al. · British Journal of Haematology · 75
PDF
Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies
2009 · Dan Grandér, Pedram Kharaziha, et al. · Autophagy · 69
PDF
Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members
2007 · E. Laane, T. Panaretakis, et al. · Haematologica · 68
PDF
Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma
2005 · Edward Laane, Edneia Tani, et al. · Cytometry Part B Clinical Cytometry · 66
PDF
The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy.
2006 · Edward Laane, Asa Rangert Derolf, et al. · PubMed · 56
The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
2015 · Iordanis Gravanis, Kyriaki Tzogani, et al. · The Oncologist · 51
PDF
Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro , Ex Vivo , and In Vivo in the 5T33MM Mouse Model
2012 · Pedram Kharaziha, Hendrik De Raeve, et al. · Cancer Research · 49
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues
2021 · Matteo D’Antonio, Jennifer P. Nguyen, et al. · Cell Reports · 45
PDF
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
2017 · Kyriaki Tzogani, Paula van Hennik, et al. · The Oncologist · 43
PDF
The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non-Hodgkin's B-Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
2013 · Elias Péan, Beatriz Flores, et al. · The Oncologist · 36
PDF
Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells
2011 · E Buentke, A Nordström, et al. · Blood Cancer Journal · 35
PDF
Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial.
2009 · Ulf-Henrik Mellqvist, Jan Westin, et al. · Blood · 28
The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
2015 · Zahra Hanaizi, Beatriz Flores, et al. · The Oncologist · 24
PDF
Dendritic Cells in Bone Marrow at Diagnosis and after Chemotherapy in Adult Patients with Acute Myeloid Leukaemia
2014 · Å. R. Derolf, E. Laane, et al. · Scandinavian Journal of Immunology · 22
PDF
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
2019 · Jacky K. Yu, Alfonso Iorio, et al. · Research and Practice in Thrombosis and Haemostasis · 20
PDF
Improved progression free survival with bortezomib consolidation after high dose melphalan: results of a randomised phase III trial
2011 · Mellquist, U. H., Gimsing, P, et al. · University of Southern Denmark Research Portal (University of Southern Denmark) · 18
The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review
2022 · Sam Salek, Tatiana Ionova, et al. · Cancers · 17
PDF
Works count: 78
Citation count: 3,095
H-index: 22
I10-index: 31
Year
Topic
Type